• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Health

Dow Chemical Asks Trump Officials to Ignore Damning Pesticide Reports

By
Sy Mukherjee
Sy Mukherjee
Down Arrow Button Icon
By
Sy Mukherjee
Sy Mukherjee
Down Arrow Button Icon
April 20, 2017, 3:33 PM ET

Updated 5:40pm, 4/20: A statement from Dow Chemical has been added to this story.

Dow Chemical asked three high-ranking Trump administration officials to ignore government scientists’ own studies about the environmental risks posed by a major class of pesticides, according to the Associated Press.

The AP got its hands on letters that Dow sent to the Secretaries of Commerce and the Interior (Wilbur Ross and Ryan Zinke, respectively) and Environmental Protection Agency (EPA) administrator Scott Pruitt—a noted opponent of environmental regulations and climate change skeptic who’s already moved to scrap Obama-era restrictions on certain pesticides. Last month, Pruitt reversed his own agency’s proposal to ban chlorpyrifos, which has been linked to brain damage in children exposed to the pest-killer.

It was against this backdrop that Dow, along with two other pesticide manufacturers, asked Trump officials to disregard government research that indicates a group of commonly used agriculture pesticides are harmful to 1,800 endangered and critically threatened animal species. In response, Dow is claiming these findings are flawed and should be “set aside” by the White House when considering proposed environmental protection rules. (When a team of the company’s own scientists examined the matter, Dow said, they came back with different results.)

Meanwhile Brett Hartl, a government scientist, is worried about how these chemicals could impact human health. “Endangered species are the canary in the coal mine,” he told the AP, since many of them reside in lakes and streams that serve as sources for human drinking water.

In response to the story, Dow said:

“No pest control product has been more thoroughly evaluated, with more than 4,000 studies and reports examining chlorpyrifos in terms of health, safety and the environment. Chlorpyrifos is authorized for use not only in the U.S., but nearly 100 nations, including Australia, Brazil, Canada, Italy and Japan. Dow AgroSciences remains confident that authorized uses of chlorpyrifos products offer wide margins of protection for human health and safety…

…Dow actively participates in policymaking and political processes, including political contributions to candidates, parties and causes, in compliance with all applicable federal and state laws. Dow maintains and is committed to the highest standard of ethical conduct in all such activity.”

 

“We have had no meetings with Dow on this topic and we are reviewing petitions as they come in, giving careful consideration to sound science and good policymaking,” J.P. Freire, the EPA’s associate administrator for public affairs, told the outlet. “The administrator is committed to listening to stakeholders affected by EPA’s regulations, while also reviewing past decisions.”

Dow is currently in the midst of a $62 billion attempted merger with DuPont; the companies received a regulatory thumbs-up from the European Union after agreeing to make big divestitures and split into three separate publicly traded companies after the corporate marriage.

About the Author
By Sy Mukherjee
See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Lists Calendar
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Lists Calendar
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Health

ken
Commentary250 Years of Innovation
The longevity revolution is here. Our systems still think we die at 65
By Ken DychtwaldApril 23, 2026
42 minutes ago
cdc
PoliticsCDC
CDC blocks release of study on COVID vaccine effectiveness
By Mike Stobbe and The Associated PressApril 23, 2026
4 hours ago
Sad nurse sitting on stairs reading bad news on mobile phone
Economygig economy
The tech industry is applying an Uber-style ‘gigification’ model to nursing. It means no workers’ comp, AI managers, and ‘surveillance wages’
By Tristan BoveApril 23, 2026
4 hours ago
Ritual Protein Review (2026): Expert Tested and Approved
HealthDietary Supplements
Ritual Protein Review (2026): Expert Tested and Approved
By Christina SnyderApril 22, 2026
1 day ago
Billionaire Michael Dell started his company in his University of Texas dorm room. Now, he’s betting on AI with a $750 million gift
HealthMichael Dell
Billionaire Michael Dell started his company in his University of Texas dorm room. Now, he’s betting on AI with a $750 million gift
By Sydney LakeApril 22, 2026
1 day ago
Everlywell At-Home Test Review (2026): Our Honest Thoughts
HealthDietary Supplements
Everlywell At-Home Test Review (2026): Our Honest Thoughts
By Emily PharesApril 22, 2026
1 day ago

Most Popular

When interest on national debt overtook military spending, it triggered a limit where the U.S. may ‘cease to be a great power,’ warns Hoover historian
Economy
When interest on national debt overtook military spending, it triggered a limit where the U.S. may ‘cease to be a great power,’ warns Hoover historian
By Eleanor PringleApril 23, 2026
10 hours ago
Cursor’s 25-year-old CEO is a former Google intern who just inked a $60 billion deal with SpaceX
AI
Cursor’s 25-year-old CEO is a former Google intern who just inked a $60 billion deal with SpaceX
By Marco Quiroz-GutierrezApril 22, 2026
1 day ago
Officials will flush 50,000 toilets to flood a Utah lake in order to generate electricity
Environment
Officials will flush 50,000 toilets to flood a Utah lake in order to generate electricity
By Mead Gruver, Dorany Pineda and The Associated PressApril 22, 2026
1 day ago
‘Something sinister’: What we know about the FBI probe into dead and missing scientists linked to space and military industries
Economy
‘Something sinister’: What we know about the FBI probe into dead and missing scientists linked to space and military industries
By Jim EdwardsApril 22, 2026
1 day ago
'Something sinister could be happening': FBI looks into dead or missing nuclear and space defense scientists tied to NASA, Blue Origin, and SpaceX
Politics
'Something sinister could be happening': FBI looks into dead or missing nuclear and space defense scientists tied to NASA, Blue Origin, and SpaceX
By Catherina GioinoApril 21, 2026
2 days ago
Craving work-life balance is a huge red flag, says Fortune 500 Europe CEO—and like Barack Obama, he happily works through weekends
Success
Craving work-life balance is a huge red flag, says Fortune 500 Europe CEO—and like Barack Obama, he happily works through weekends
By Orianna Rosa RoyleApril 22, 2026
2 days ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.